EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation

Anna E Mammel, Fernando Gonzalez-Ortiz, Ali Mousavi, Kelsey Hallett, Mary Encarnacion, Don Biehl, Pradip Gill, Sazan Ismael, Christopher Fowler, James D Doecke, Larry Ward, Hans Frykman

Alzheimer's & Dementia · 2026-06 · 22 (6)

DOI: 10.1002/alz.71532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.06.2026. Verfasst von Anna E Mammel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neurocode USA Inc, Bellingham, Washington, USA. Hauptthemen laut MEDLINE: Aging, Amyloid beta-Peptides, tau Proteins. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The extent to which non‐pathological aging influences plasma biomarkers remains unclear. Here, we investigate factors influencing plasma p‐tau217 levels in cognitively unimpaired (CU), amyloid‐beta–negative (Aβ‐) individuals. METHODS Plasma p‐tau217 was measured in CU Aβ‐ positron emission tomography–negative (PET‐) participants using two immunoassays (ALZpath n = 360 and LUMIPULSE G1200 n = 73). Associations between p‐tau217 and age groups (60–69, 70–79, and 80+ years), apolipoprotein E ( APOE) genotype, and gender were evaluated. RESULTS ALZpath plasma p‐tau217 showed a non‐pathological age‐related increase ( p < 0.001), and increased percentage within the intermediate zone with age. Lumipulse p‐tau217 showed an increase in the percentage of subjects with positive results with age, however, this trend was not significant ( p > 0.05). Men had higher levels of p‐tau217 only with the ALZpath assay ( p = 0.02; Lumipulse: p = 0.81). No significant associations were found between p‐tau217 and APOE genotype. DISCUSSION Our results highlight the importance of incorporating age and sex into the interpretation of plasma p‐tau217 particularly in preclinical stages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingAmyloid beta-Peptidestau ProteinsHumansMaleFemaleAgedApolipoproteins EBiomarkersAged, 80 and overMiddle AgedPositron-Emission TomographyGenotype

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerscognitively normalnormal agingplasma p‐tau217

Substanzen

Amyloid beta-PeptidesApolipoproteins EBiomarkerstau Proteins

Autor:innen und Institutionen

  • Neurocode USA Inc, Bellingham, Washington, USA.
  • University of Gothenburg, Gothenburg, Sweden.
  • BC Neuroimmunology Laboratory, Vancouver, British Columbia, Canada.
  • Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • The Florey Institute of Neuroscience and Mental Health, the University of Melbourne, Parkville, Victoria, Australia.
  • The Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Queensland, Australia.

Zitieren

APA

Mammel, A. E., Gonzalez-Ortiz, F., Mousavi, A., Hallett, K., Encarnacion, M., Biehl, D., Gill, P., Ismael, S., Fowler, C., Doecke, J. D., Ward, L., & Frykman, H. (2026). Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71532

Vancouver

Mammel AE, Gonzalez-Ortiz F, Mousavi A, Hallett K, Encarnacion M, Biehl D, et al. Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71532

BibTeX
@article{Mammel2026,
  author = {Mammel, Anna E and Gonzalez-Ortiz, Fernando and Mousavi, Ali and Hallett, Kelsey and Encarnacion, Mary and Biehl, Don and Gill, Pradip and Ismael, Sazan and Fowler, Christopher and Doecke, James D and Ward, Larry and Frykman, Hans},
  title = {Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {6},
  doi = {10.1002/alz.71532}
}
Kostenlos starten →